FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us

Resources

  • Videos
  • Research Reports
  • FAQ

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Alpha Teknova, Inc. Stock AnalysisComprehensive stock analysis for Alpha Teknova, Inc. (TKNO) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisTKNO
TKNO
Alpha Teknova, Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
TKNO
Home🔹Stocks🔹Alpha Teknova, Inc.

Alpha Teknova, Inc.

TKNO•NASDAQ

Alpha Teknova, Inc.

TKNO•NASDAQ
Market cap
$272.90M
Sentiment

Your view on TKNO

Mkt Cap
$272.90M
Sentiment
Your view
TKNO
Alpha Teknova, Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
TKNO
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Alpha Teknova, Inc.

Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
Stephen Gunstream
Headquarters
2290 Bert Drive, Hollister, CA, US
Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
Stephen Gunstream
Headquarters
2290 Bert Drive, Hollister, CA, US
Description

Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It serves life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and government research institutions. The company was founded in 1996 and is headquartered in Hollister, California.

Infographics

Visual summary of the business at a glance.

FRC Research

Media

Videos and interviews covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks the stock is worth vs. the current price.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Peer Comparison

Comparables

List of peer companies in the same industry.

Ownership & News

Institutional Ownership

Which funds and firms own the stock.

Insider Trading

Recent buying and selling by company executives.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

News

Latest headlines and market coverage.

News

Latest Market News